Skip to main content
Year archive

BRAIN Biotech AG — 2022 filings

All 40 regulatory filings released by BRAIN Biotech AG (BNN) in 2022, sourced directly from the official regulator.

40 Filings
2022 Period
2022 filings (40)
Filing Released Lang
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-11-22 English
BRAIN Biotech AG: MP Beteiligungs-GmbH Increases Stake in BRAIN Biotech AG
Major Shareholding Notification
2022-11-17 English
BRAIN Biotech and Bonumose collaborate on enzymes for the production of rare monosaccharides
Regulatory Filings
2022-10-25 English
EQS-DD: BRAIN Biotech AG english
Director's Dealing
2022-10-13 English
EQS-DD: BRAIN Biotech AG english
Director's Dealing
2022-10-13 English
EQS-DD: BRAIN Biotech AG english
Director's Dealing
2022-10-13 English
EQS-DD: BRAIN Biotech AG english
Director's Dealing
2022-10-13 English
Change in the Executive Management Board of BRAIN Biotech AG, genome editing activities established under the Akribion Genomics brand
Board/Management Information
2022-09-27 English
BRAIN Biotech AG sells subsidiary L.A. Schmitt to a URI group company
M&A Activity
2022-09-26 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-09-14 German
BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting
Earnings Release 9M 2022
2022-08-29 English
Q3 statement / Q3 financial report 2021/2022
Interim / Quarterly Report Q2 2022
2022-08-29 German
BRAIN Biotech publishes first ESG and Sustainability Report
Environmental & Social Information
2022-06-20 English
Half-yearly financial report 2021/2022
Interim / Quarterly Report H2 2022
2022-06-03 German
BRAIN Biotech AG: Prof. Dr. Bernhard Hauer leaves Supervisory Board of BRAIN Biotech AG for personal reasons
Board/Management Information
2022-05-30 English
BRAIN Biotech AG: Ongoing Dynamic Sales Development and Rising Profitability, 6M Reporting
Earnings Release H1 2022
2022-05-30 English
Halbjahresfinanzbericht
Interim / Quarterly Report H1 2022
2022-05-30 German
Report Publication Announcement 2022
Report Publication Announcement
2022-05-23 English
Hinweis auf Halbjahresfinanzbericht vom 01.10.2021 bis zum 31.03.2022
Report Publication Announcement
2022-05-23 German
Hinweis auf Halbjahresfinanzbericht vom 01.10.2021 bis zum 31.03.2022
Report Publication Announcement
2022-05-23 German
DGAP-DD: BRAIN Biotech AG english
Director's Dealing
2022-04-07 English
DGAP-DD: BRAIN Biotech AG english
Director's Dealing
2022-04-07 English
BRAIN Biotech AG: Successful Genome Editing in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC)
Regulatory Filings
2022-04-04 English
BRAIN Biotech AG: Successful Genome Editing Activity in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC)
Regulatory Filings
2022-04-04 English
BRAIN Biotech AG: Resolutions of the Annual General Meeting for the Fiscal Year 2020/2021 of BRAIN Biotech AG
AGM Information
2022-03-09 English
Q1 statement / Q1 financial report 2021/2022
Interim / Quarterly Report Q4 2021
2022-02-25 English
BRAIN Biotech AG: Very Dynamic Start into the Fiscal Year 2021/22, 3M Reporting
Earnings Release Q1 2021
2022-02-23 English
Jahresabschluss zum Geschäftsjahr vom 01.10.2020 bis zum 30.09.2021
Annual Report FY 2021
2022-02-22 German
Konzernabschluss zum Geschäftsjahr vom 01.10.2020 bis zum 30.09.2021
Annual Report (ESEF) FY 2021
2022-02-22 German
BRAIN Biotech and Formo: Strategic partnership of European biotech experts for the production of animal-free milk protein
M&A Activity
2022-02-08 English
BRAIN Group significantly expands its food enzyme business with the acquisition of Breatec B.V. and Comix business
Regulatory Filings
2022-02-01 English
BRAIN Biotech AG: BRAIN Group expands its food enzyme business with the acquisition of a majority of Breatec B.V. and Comix
M&A Activity
2022-02-01 English
BRAIN Biotech AG: Bekanntmachung der Einberufung zur Hauptversammlung am 09.03.2022 in Offenbach am Main mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2022-01-28 German
Annual financial report 2020/2021
Annual Report FY 2021
2022-01-18 English
BRAIN Biotech AG publishes Annual Report for FY 2020/21
Report Publication Announcement
2022-01-17 English
BRAIN Biotech AG: BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology
Legal Proceedings Report
2022-01-11 English
BRAIN Biotech AG: BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology
Regulatory Filings
2022-01-11 English
Report Publication Announcement 2022
Report Publication Announcement
2022-01-10 English
Hinweis auf Jahresfinanzbericht vom 01.10.2020 bis zum 30.09.2021
Report Publication Announcement
2022-01-10 German
Hinweis auf Jahresfinanzbericht vom 01.10.2020 bis zum 30.09.2021
Report Publication Announcement
2022-01-10 German